|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Thompson
CEO | Chief Executive Officer | 57 | - |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | ||
| +0.98% | +2.68% | +12.25% | +83.90% | 55.53B | ||
| +1.75% | +2.01% | +13.30% | +105.71% | 53.03B | ||
| -2.00% | -1.79% | +25.48% | +54.28% | 45.99B | ||
| -1.06% | -3.41% | +17.27% | +97.86% | 42.45B | ||
| -0.41% | +0.31% | +224.49% | +925.99% | 40.45B | ||
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | ||
| -2.07% | +42.73% | +103.77% | +90.26% | 34.47B | ||
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | ||
| Average | -0.64% | +3.82% | +51.94% | +162.07% | 43.62B | |
| Weighted average by Cap. | -0.37% | +3.13% | +49.03% | +159.78% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















